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Edited by Thomas So¨llnerAbstract The mechanism of sperm–egg fusion in mammals is a
research area that has greatly beneﬁted from the use of gene
deletion technology. Because fertilization is internal in mammals
and the gametes (particularly the eggs) are sparse in number,
in vitro studies have considerable limitations. Using gene dele-
tions, a few cell surface proteins in both gametes have been iden-
tiﬁed as essential for gamete fusion. Ongoing studies are directed
at analysis of the function of these proteins and the search for
additional proteins that may be involved in this process. So
far, no mammalian proteins have been found that also function
in sperm–egg fusion of non-mammalian species or in other types
of cell–cell fusion.
 2007 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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1.1. Biology of mammalian sperm–egg fusion
In mammals, the male and female gametes remain physically
separated until just prior to the moment of fusion. Both sperm
and egg are primed for fusion before contact between the two
cells, although potentially further changes are required after
contact. Following fusion of the ﬁrst sperm with the egg mem-
brane, the chances of a second sperm fusing are reduced. This
change in the zygote membrane contributes to the prevention
of polyspermy.
During oocyte growth, the oocyte plasma membrane ac-
quires the competence for fusion. Small mouse oocytes from
primordial follicles are not capable of fusion with sperm, but
at a diameter of about 20 lm, while the oocyte is still arrested
in prophase of ﬁrst meiotic division, fusion can occur [1]. Dur-
ing normal in vivo fertilization the oocyte will not meet the
sperm until ovulation of an 80 lm diameter oocyte that is ar-
rested in metaphase II.
Maturation of the sperm, prior to fusion, occurs in three
successive steps. Sperm released from the testis are not capable
of fusion, even though they have completed protein synthesis.*Corresponding author. Fax: +1 530 752 8520.
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female reproductive tracts. Post-testicular sperm maturation
begins during epididymal passage in the male. Subsequent
maturation occurs in the female reproductive tract, but can
be mimicked in vitro. This maturation includes changes
brought about by the sperm’s environment (either in the fe-
male reproductive tract or in vitro by media of known compo-
sition). These changes are collectively referred to as sperm
capacitation. Capacitation results in altered patterns of sperm
motility and the ability of the sperm to undergo regulated exo-
cytosis (acrosome reaction). Although sperm maturation dur-
ing these steps is required for gamete fusion, key required
changes (whether surface or intracellular) have not yet been
determined [2].
Prior to acrosomal exocytosis, the sperm push their way be-
tween the cumulus cells that surround the egg at ovulation.
The acrosome reaction occurs upon sperm binding to the zona
pellucida and is triggered by ligands that comprise this extra-
cellular coat of the egg [2]. The last step prior to fusion is
the penetration of the sperm through the zona pellucida.
Sperm must be acrosome-reacted to penetrate the zona and
fuse with the egg. Indeed the acrosome reaction appears to be
required for sperm to fuse with the egg membrane even when
the zona has been removed in vitro. Due to the acrosome reac-
tion, the composition of the sperm membrane is altered by the
incorporation of the inner region of the acrosomal membrane
into the plasma membrane, with the subsequent relocalization
of some membrane proteins into other membrane regions (e.g.
PH-20, Izumo) [3,4]. The relocalization of PH-20 occurs by its
diﬀusion in the lipid bilayer. For other proteins it remains a
matter of debate whether this change in protein location oc-
curs by protein diﬀusion through the lipid bilayer or by release
of these molecules (perhaps in membrane vesicles) and then
reassociation with the sperm plasma membrane. Additional
alterations of sperm membrane molecules may occur as the re-
sult of release of acrosomal contents that can also bind to the
plasma membrane and/or alter it by enzymatic activity (e.g.,
proteases and glycosidases). The observation that acrosome-
intact sperm can bind to zona-free eggs, but do not fuse with
them, suggests that membrane alterations occurring during
the acrosome reaction are required for fusion [2].
After sperm enter the perivitelline space they attach to the
egg membrane. Whether or not this attachment/binding in-
volves the same molecules that participate in membrane fusion
has not been determined. In the in vitro fusion assay with zona-
free eggs, many sperm attached to the eggs are acrosome-intact
and do not fuse. Also many more acrosome-reacted sperm bindation of European Biochemical Societies.
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of bound spermmay outnumber fused sperm 10–1. The binding
therefore could be artifactual and not represent a required step
that precedes fusion of the lipid bilayers. Even if a binding step
prior to the engagement of the fusion machinery is required, we
do not currently have the ability to diﬀerentiate between a phys-
iological binding of sperm leading to fusion from the simple
non-physiological sperm sticking that obviously is observed
in the in vitro assays [5].
On the egg, a speciﬁc subdomain of the plasma membrane
participates in the initial merger of the two lipid bilayers.
The egg plasma membrane can be divided into two major re-
gions. The part of the membrane that directly overlies the
metaphase chromosomes has a smooth surface devoid of
microvilli. It has been described by several investigators that
sperm are observed to neither bind nor fuse in this region [2]
and this sperm behavior has been clearly visualized by electron
microscopy (Fig. 1). The remainder of the egg is rich in micro-
villar protrusions. This is the region of the egg where sperm
both bind and fuse. Because of the geometry of sperm associ-
ation with the egg microvilli, it may be the microvillar mem-
brane itself or the tip of the microvillar membrane that fuses
with the sperm (see CD9 below).
Like the egg, the sperm is restricted in the region of its plas-
ma membrane that participates in the initial fusion (Fig. 2).
The regions excluded from the initial fusion are the plasmaFig. 1. Sperm bind to the region of the oocyte with a high
concentration of microvilli. (A) Wild-type oocyte showing microvilli-
free (*) and microvilli-rich regions. (B) Wild-type oocyte after
incubation with sperm for 25 min. Sperm are not bound to microvilli
free region. Bars, 20 lm.
Fig. 2. Diagram based on electron micrographs depicting acrosome-
reacted sperm fusing with the egg surface. The sperm cytoplasm is in
red; the egg cytoplasm in yellow; mixtures of the two cytoplasms are in
gold. In the top panel, the acrosome-reacted sperm is shown with its
head approaching egg microvilli. The ‘‘Region of Sperm Recognition
by Egg’’ is shown as the sperm equatorial region. As explained in the
text, the sperm may actually also initiate fusion with its posterior head
region plasma membrane which covers the wider, posterior region of
the sperm head. In the two middle panels, initial fusion occurs,
cytoplasmic mixing occurs and additional fusion sites arise over more
extensive regions of the gamete surfaces. In the bottom panel, the inner
acrosomal membrane which covers the anterior head but never fuses is
shown covering a sperm fragment.membrane of the tail and the newly incorporated inner acroso-
mal membrane. Images of fusion between the equatorial region
(refers to an equatorial band around the center of the sperm
head) and the egg have been published. It has been frequently
stated that only the equatorial region of the sperm can begin
fusion with the egg [2], but it would be diﬃcult, without more
extensive studies, to rule out that the posterior head plasma
membrane region also initiates fusion. As more components
of the fusion machinery are identiﬁed, their localization will al-
low a precise deﬁnition of which regions of the sperm head
plasma membrane are fusigenic.
After the acrosome reaction, the anterior part of the sperm
head is covered by the membrane that was previously the inner
acrosomal membrane. As the sperm is incorporated into the
egg cytoplasm and the two gamete membranes are merged to
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rior head membrane (inner acrosomal membrane) is excluded
from this merger. This region of the sperm membrane, fused
with a small patch of the egg plasma membrane, forms a sep-
arate detached hybrid vesicle in the cytoplasm. This has been
described as a pseudo-phagocytotic-like process.2. Gene deletion studies have identiﬁed proteins with a role in
gamete fusion
2.1. The egg
2.1.1. CD9 and its potential function(s). CD9 is a tetra-
spanin protein family member, present on the egg surface as
well as the surface of many other cell types. Tetraspanins are
found from Caenorhabditis elegans to human and often show
wide tissue distribution. In mammals there are about 35–40
family members which have a conserved structure, featuring
four passes through the membrane, one small extracellular
loop and one large extracellular loop. Tetraspanins are be-
lieved to function primarily as organizers of networks of trans-
membrane and cytoplasmic proteins. Tetraspanins associate in
cis with many other proteins, including Immunoglobulin
super-family (IgSF) proteins, integrins, and membrane-an-
chored growth factors as well as forms tetraspanin–tetraspanin
interactions. The sum of these interactions constitutes the ‘‘tet-
raspanin web’’, a large network of proteins linked by associa-
tions (direct and indirect) [6,7]. These networks can
presumably be used to execute functions that require multiple
intermolecular interactions. In addition to participation in the
tetraspanin web, some tetraspanins may also act as receptors
[8–10], but so far examples of receptor activity are few.
The initial reports that CD9 null female mice were infertile
came from three diﬀerent labs [11–13]. Eggs from the null fe-
males fail to fuse with wild-type sperm in vitro. Monoclonal
antibodies to CD9 also block fusion (>95%) in in vitro assays
[13,14]. CD9 KO eggs can be rescued by micro-injection of
eggs with wild-type mouse or human mRNA for CD9
[15,16]. However, if the mouse SFQ (173–175) sequence in
the large extracellular loop is mutated to AAA, the ability to
rescue fusion is abolished [16]. Studies of other tetraspanins
have also revealed functions in the large extracellular loop in
(or near) regions homologous to 173–175 in mouse CD9.
Three hypotheses have been suggested to explain why CD9 is
required for the gamete fusion process. CD9 may have a re-
quired cis interaction, a required trans interaction, or a required
role in membrane organization. None of these three hypotheses
excludes the others and indeed all three may prove correct.
Evidence for the ﬁrst hypothesis, that the required CD9
function depends on cis interactions, comes from experiments
in which the large extracellular loop of CD9, fused to GST or a
6· His tag, was tested for its ability to inhibit gamete fusion
in vitro. Pre-incubation of sperm with the CD9 constructs
had little or no eﬀect, while pre-incubation of eggs with either
construct resulted in a substantial inhibition of fusion [16].
This result suggests that CD9 interacts in cis with one or more
proteins and that the tetraspanin web may be active in fusion.
A second hypothesis for CD9 action, that CD9 has required
trans interactions with a sperm protein, arose ﬁrst from exper-
iments studying macrophage regulation. Pregnancy-speciﬁc
glycoprotein 17 (PSG17) is an eﬀector of cytokine productionin RAW 264.7 macrophages [17]. PSG17 is a soluble member
of the IgSF and belongs to the CEA subfamily. CD9, or a CD9
cis partner, was identiﬁed as the receptor for soluble PSG17 on
RAW 264.7 macrophages [10]. Further work showed that
PSG17 binds directly to CD9 in several types of assays. Addi-
tionally, PSG17 bound to eggs and blocked gamete fusion
in vitro [8]. The CD9-PSG17 interaction can be genetically
blocked if the recombinant CD9 protein carries the SFQ to
AAA mutation; the AAA mutant CD9 fails to bind PSG17
[8]. Together these results demonstrated that in principal
CD9 was capable of a trans interaction with an external ligand
and therefore could theoretically bind to a sperm surface pro-
tein. However, PSG17 has not been found on sperm; at least
two other CEA sub-family members are expressed on sperm,
but no evidence for their function in sperm–egg fusion has
yet been presented.
If PSG-17 is acting in trans to block sperm–egg interaction
by mimicking a sperm molecule, then why does not the soluble
large loop of CD9 inhibit fusion when pre-incubated with
sperm? This apparent disparity might be explained if we con-
sider it likely that a complex of CD9 and cis interacting pro-
teins on the egg surface would ‘‘out compete’’ a lower
aﬃnity interaction of a soluble CD9 extracellular loop bound
to the sperm.
The third hypothesis about CD9’s required action in fusion
is that it has a necessary role in membrane organization. Re-
cent evidence indicates that the requirement for CD9 on the
egg may be to maintain the proper structure or function of
egg microvilli [18]. It has recently been shown that in experi-
ments with tissue culture cells and recombinant proteins, the
cytoplasmic tails of two CD9-associated proteins, EWI-2 and
EWI-F, bind to ERM proteins (ezrin, radixin and moesin)
[19]. ERM proteins in turn bind to the actin ﬁlaments of the
microvillar core [20]. These experiments in tissue culture cells
deﬁne a network of proteins that attach CD9 on the cell sur-
face to the actin cytoskeleton, in a CD9–EWI–ERM–actin
linkage. A proteomics analysis of CD9 and its co-precipitating
proteins from eggs, showed that CD9 is associated with both
EWI-2 and EWI-F [18]. Hence, the presence of CD9 in the
egg plasma membrane may be required to maintain the dy-
namic and functional activities of this protein network and
therefore the normal properties of egg microvilli.
Furthermore, immunoﬂuorescence microcopy shows that
CD9 is localized to the microvillar-rich region of the egg [11];
and a recent EM study showed that CD9 is largely localized
to the microvillar membrane compared to the planar mem-
brane between the microvilli [18]. Morphological comparison
of the microvilli from CD9 KO eggs with those from wild-type
eggs shows that the CD9 null microvilli are shorter, fatter and
more densely distributed. The wild-type microvilli, on average
are longer and thinner and have an 2-fold smaller radius of
curvature at the microvillar tip [18]. As pointed out above,
the microvillar-rich region of the egg plasma membrane is the
domain where the sperm fuses. One potential role of the micro-
villi is to provide a small radius of curvature at the position
where fusion occurs. In some systems, for example sea urchin
fertilization and Chlamydomonas gamete fusion, the fusion
structure also has a small radius of curvature and it has been
suggested that this small radius could promote fusion [21].
Remarkably, it has been reported that CD9 in other cell
types shows a negative (not a positive) regulation of membrane
fusion [22]. Fusion of monocytes to form multi-nucleated
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deﬁcient cells than in wild-type cells. The incidence of fusion
is even higher in cells where both CD9 and a closely related tet-
raspanin, CD81, have been deleted. Furthermore, anti-CD9
and anti-CD81 monoclonal antibodies stimulate fusion to
form giant cells [22]. These results could mean that CD9 has
cell type-speciﬁc partners that are critical regulators of fusion.
Alternatively, diﬀerent cell types may have diﬀerent core mem-
brane fusion machineries that have diﬀerent interactions with
CD9.
2.1.2. CD81 and its relationship to CD9. There is evidence
that a second tetraspanin, CD81, which fairly closely resembles
CD9 in structure and some functions, has a role in gamete fu-
sion [23]. However, the results of deleting the CD81 gene are
less dramatic than those seen with the deletion of CD9.
CD81 KO mice are impaired in their fertility, but the impair-
ment is relatively mild. The reduced fertility was not seen in
the originally derived mice, but became apparent when they
were backcrossed (4–5 times) with either C57BL/6 or Balbc.
An extended test of in vivo mouse mating was carried out
where mating was ongoing for a period of at least 60 days in
contrast to the more usual mating period of 3–4 weeks. During
this extended in vivo mating, many (60%) of CD9 KO or CD81
KO females became pregnant while 100% of wild-type females
became pregnant. However, the CD9 null females gave much
smaller litters and showed much longer delays in pregnancy
than CD81 null or wild-type females. Using these parameters,
the authors calculate a 40% reduction in fertility for CD81 KO
and a 95% reduction in fertility for CD9 KO females. Double
KOs for the two tetraspanins showed complete infertility. In
vitro, both CD9 KO and CD81 KO eggs were >95% inhibited
in fusion [23].
Some investigators found that CD9 null eggs micro-injected
with CD81 mRNA showed rescue of fusion competence, but
this required over-expression of CD81 and long insemination
times [15]. Others found that injection of CD81 mRNA failed
to rescue the CD9 KO inability to fuse (K. Miyado and E.
Mekada, personal communication). It remains unclear from
these data whether CD9 and CD81 have redundant functions
or two distinct functions whose loss delivers one or another
distinct blow to the fusion process.
2.1.3. GPI-anchored proteins. Two separate types of studies
have implicated egg surface GPI-anchored proteins in sperm–
egg fusion. First, GPI-anchored proteins were removed from
the egg surface by a bacterial-derived PI-PLC. Treatment of
eggs with the enzyme for 30 min blocked their fusion capability
(90%) [24]. Second, conditional knockout mice were gener-
ated with an egg-speciﬁc deletion of the enzyme Pig-a, which
encodes the ﬁrst enzyme in the biosynthetic pathway of the
GPI-anchor. The female mice lacking the Pig-a gene were infer-
tile (0/10 had pregnancies) while wild-type females (10/10) were
fertile [25]. Eggs recovered from the conditional mutant females
after mating were unfertilized. In in vitro assays, the Pig-a
null eggs were unable to fuse with sperm [25]. Taken together
these results provide strong evidence for a speciﬁc requirement
of egg GPI-anchored proteins at the time of fusion.
These results leave open the two obvious possibilities that
absence of multiple (or all) egg GPI-anchored proteins or ab-
sence of a single key GPI-anchored protein is suﬃcient to give
the phenotype. Ongoing work on the GPI-anchored class of
proteins on eggs should allow identiﬁcation of which of these
proteins acts in fusion.2.2. The sperm
2.2.1. Izumo, a novel Ig super family protein. The protein
Izumo was ﬁrst identiﬁed by the ability of the anti-Izumo
monoclonal antibody (OBF13) to inhibit sperm–egg fusion
in vitro [26] and was more recently analyzed in Izumo null
mice [3]. Izumo appears to show testis and sperm speciﬁc
expression. Male mice carrying a deletion of the Izumo gene
were sterile; nine mating pairs over a four month period using
Izumo null males and wild-type females produced no pups.
Izumo KO sperm showed normal motility, normal migration
into the oviduct, and normal acrosome reaction. In vitro fertil-
ization assays revealed that the mutant sperm penetrated the
zona pellucida at normal levels, but were found to accumulate
in the perivitelline space. Using zona-free eggs in vitro, Izumo
null sperm showed no sperm fusion, even under conditions
where wild-type sperm resulted in polyspermic eggs (4.5 sperm
fused/egg in 2 h or 6 sperm fused/egg after 6 h) [3]. When Izu-
mo null sperm were used in intra-cytoplasmic sperm insemina-
tion (ICSI), they produced as many oﬀspring as wild-type
sperm, indicating that developmental stages beyond fusion
are unaﬀected. Also in a male mouse carrying an Izumo trans-
gene driven by a calmegin promoter, the sterile phenotype was
rescued showing that the sterility arose strictly from the lack of
Izumo and not by disruption of additional genes [3].
Izumo is a novel member of the IgSF and apparently lacks
paralogs. Orthologs are present in other mammals, including
one on human sperm. Izumo is comprised of 397 residues with
a single Ig domain in roughly the middle of the extracellular
domain. At the C-terminus it has a transmembrane region
and a short cytoplasmic tail [3].
No speciﬁc function for Izumo in the fusion process has been
determined. Like many cell surface IgSF proteins, it could act
in cell–cell adhesion. Egg CD9, or one of its cis partners, is an
attractive candidate for an Izumo adhesion partner, but no
data supporting this notion have appeared. Several IgSF pro-
teins have been found to act in Drosophila myoblast fusion and
there is considerable information about their expression and
sub-cellular localization in myoblast founder cells and/or fu-
sion competent cells [27,28]. However, this information has
not yet led to a model for how these proteins’ interactions lead
to bilayer mixing. Thus, while IgSF proteins clearly have re-
quired roles, they have not yet given insight into the nature
of the fusion machinery.3. Other gamete proteins with a proposed function in
sperm–egg fusion
Several other gamete surface proteins have been identiﬁed as
having a potential role in sperm–egg fusion based on antibody
inhibition of fusion or inhibition of fusion by puriﬁed proteins,
recombinant fragments or peptides from the particular pro-
tein.
One of the more-studied of these proteins is the sperm-asso-
ciated DE. DE is made and secreted by the epithelial cells of
the epididymis. It associates with the sperm plasma membrane
as sperm traverse the epididymis. A fraction of this absorbed
DE is tightly bound to the sperm surface and can not be re-
moved by high ionic strength washes [29]. A possible activity
of DE in fusion is supported by fusion inhibition by an anti-
DE polyclonal antibody [30]. Furthermore, puriﬁed DE binds
to the microvillar-rich region of the egg and its binding inhibits
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of the gene, will be necessary to deﬁne its precise role.
Anti-ADAM antibody and ADAM protein/peptide fusion
inhibition studies have also suggested a role for ADAM pro-
teins on sperm [32–34]. Since sperm ADAMs contain a disin-
tegrin domain which could potentially bind to an egg
integrin, a model for sperm–egg fusion was developed where
ADAM-integrin binding led to fusion [35].
The speciﬁc egg integrin identiﬁed by antibody inhibition
studies as functioning in gamete fusion was a6b1 [36]. How-
ever, knock out of the integrin subunit a6 has no eﬀect on
in vivo or in vitro fertility [14]. Furthermore, female mice were
tested carrying gene deletions of all the integrins known to be
present on eggs or identiﬁed as ADAM receptors. These
knockout females had normal in vivo fertility and their eggs
had normal ability to fuse with sperm in vitro [37]. Also re-test-
ing of the anti-a6b1 antibody under in vitro conditions that
more closely resembled in vivo conditions found that this anti-
body (GoH3) did not block fusion [14]. Thus, the integrins can
now be reasonably dismissed as fusion-related unless new,
compelling evidence for their role is presented.
The original sperm ADAMs studied were ADAM2 and
ADAM3. An anti-ADAM2 Mab partially inhibits fusion.
When eggs are pre-incubated with short peptides correspond-
ing to the ADAM2 or ADAM3 disintegrin domain, their abil-
ity to fuse with sperm is inhibited. Despite this collection of
in vitro evidence, deletion of the genes for ADAM2 or
ADAM3 or both shows little eﬀect on sperm fusion compe-
tence [38–40]. The paradoxical quality of these results is not
yet understood but may arise from the large number of sperm
ADAMs. There are 40 ADAMs of which 15 are predomi-
nantly or exclusively expressed in testis. One of these other
unstudied ADAMs might have a disintegrin domain and anti-
body epitopes that resemble ADAM2 or ADAM3. This
ADAM might bind to a novel ADAM receptor (not an inte-
grin) on the egg and act in fusion.4. Comparison of mammalian sperm–egg fusion to
sperm–egg fusion in model systems
While many problems have been solved (at least in part) by
use of eukaryotic model systems (yeast, C. elegans, Drosophila,
Arabadopsis), the hope of doing this for gamete fusion has not
yet been realized. So far no studies have revealed non-verte-
brate orthologs of CD9, CD81 or Izumo acting in fusion
and non-vertebrate, fusion-related proteins have not been
found in mammals. Nonetheless, it is early in the search and
a basic shared mechanism may yet be discovered.
4.1. Drosophila melanogaster
So useful in identiﬁcation of genes involved in speciﬁc func-
tions, D. melanogaster may be of little help in studying sperm–
egg fusion. In this organism, fusion of the two gamete plasma
membranes has not been detected, but instead the intact sperm
plasma membrane can be found in the egg cytoplasm. This
process has recently been shown quite clearly with the aid of
a mutant sperm that lacks a gene required for sperm plasma
membrane breakdown in the egg, allowing extra time for
observation of the sperm plasma membrane [41]. Amazingly,
this process does not appear to involve an endocytotic or
phagocytotic engulfment as the egg plasma membrane hasnot been found surrounding the sperm. Such an engulfment
of the sperm in an egg plasma membrane vesicle has been de-
scribed for some species of nematodes [42]. Therefore, how the
Drosophila sperm reaches the interior of the egg is not yet
understood.4.2. Caenorhabditis elegans
For many years there was also uncertainty about whether
actual membrane fusion occurs between the gametes of C. ele-
gans. Recent TEM studies have obtained images consistent
with a true fusion event and the identiﬁcation of proteins re-
quired in this step has been the goal of genetic screens. These
studies, like other sperm–egg fusion studies, are complicated
by the multiple steps leading up to fusion, but both sperm
and egg proteins required for gamete membrane interaction
leading to fusion have been identiﬁed. On the sperm side, it
was found that sperm with a mutation in the Spe9 gene can
be blocked in fertilization at the step where sperm and egg
are in the same compartment [43]. Spe 9 on the sperm has 10
EGF domains in its extracellular region which may carry out
diﬀerent functions, but its actual role in fertilization is not
yet clear [44]. In eggs, two recently described mutants in genes
egg-1 and egg-2 allow sperm–egg contact but not fusion. The
EGG1 and EGG2 gene products have multiple LDL receptor
domain-Type a repeats in their extracellular region and could
be adhesion proteins [45].
New information about the role of the EFF-1 protein in
cell–cell fusion in C. elegans epithelia does not lead to a model
for sperm–egg fusion in C. elegans. EFF-1 has not been found
to be expressed in either gamete and eﬀ-1 gene deletion does
not aﬀect fertility [46].4.3. Plants
Recent research has identiﬁed a sperm-speciﬁc protein called
GCS1 (for Generative Cell Speciﬁc 1) [47]. GCS1 is present on
the plasma membrane of the generative cell (the precursor of
the two sperm cells) and the sperm cells. This protein contains
a putative N-terminal signal sequence, and a potential trans-
membrane domain followed by a histidine-rich region in the
C-terminal region. A disruption of the GCS1 gene resulted
in infertile pollen that does not produce normal seeds. Close
examination of the phenotype demonstrated normal steps in
both pollen tube development and fertilization preceding fu-
sion up until the point when sperm cells have access to the
egg plasma membrane [47]. This is strong evidence that
sperm–egg attachment or membrane fusion is defective. Be-
cause this is a novel protein with no obvious functional do-
main, the mechanism of its action is a mystery. The protein
is not conﬁned to angiosperms, but has been reported in the
gametes of the green alga, Chlamydomonas reinhardtii, where
it is expressed strongest in the male gamete and also in Physa-
rum polycephalum where it is found in both gametes [47]. Fur-
thermore homologues have been found in red algae and
parasites (Plasmodium falciparum and Leishmania major).
Previously another protein, Fus1, was reported in Chla-
mydomonas reinhardtii to be associated with the mt+ gamete
and to play a role in fertilization [48]. Fus1 is a 95kD protein
that is present on the mt+ gamete surface in the region of the
fertilization structures; fus1 mutations prevent the gamete
adhesion that normally occurs with the mt gamete. Sequence
analysis predicts that Fus1 is a single pass transmembrane
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teristics shared with bacterial invasins and intimins that func-
tion in bacterial adhesion [48]. Whether Fus1 has a role in lipid
bilayer fusion or interacts with the GCS1 protein is not yet
known.
4.4. Yeast
Another possible model for understanding mammalian
sperm–egg fusion is the fusion of haploid cells of opposite mat-
ing types during yeast mating. As in mammalian and other
types of fertilization, yeast mating requires multiple steps,
including alterations in the haploid cells and cell wall dissolu-
tion so that the two plasma membranes can be brought into
contact. Two cell surface proteins have been identiﬁed that
function at the end of this series of steps at the time of mem-
brane fusion [49,50]. In the absence of the Prm1 protein in
both cells of a mating pair, 40% of the pairs remain closely
associated but with their membranes unfused [50]. Another
20% of the pairs lyse [51]. A similar but less dramatic eﬀect
is observed in the absence of a second protein Fig1 [49]. With
both members of the mating pair lacking Fig1, there is a 25%
reduction in fusion, by arrest or lysis of mating pairs. To reach
a 90% reduction in fusion both proteins must be missing. From
these results it is possible to conclude that the proteins have a
role in fusion, but their role is either non-essential or redun-
dant with a diﬀerent fusion pathway. How the proteins func-
tion is also not yet clear. One suggestion is that in part they
function to form a ‘‘molecular fence’’ to contain or corral
the fusion machinery thereby increasing eﬃciency of fusion
and preventing cell lysis [49]. As other proteins are identiﬁed
that increase the fusion impairment of Prm1-deﬁcient cells
[52], this situation should clarify.5. Does sperm–egg fusion resemble virus–cell fusion or
intracellular membrane fusion systems?
Chen and Olson have argued that, given current data, cell–
cell fusion will prove to be substantially diﬀerent from virus–
cell or intracellular fusion. In particular, cell–cell fusion will
not use a mechanism based on fusion protein alpha-helical
bundles creating a hairpin-like structure that brings the mem-
branes into close proximity [27].
There is of course the possibility that some features of cell–cell
fusion might use regulatory (or other) mechanisms that are con-
served. One recently studied example of a potential similarity
between viral–host cell fusion and sperm–egg fusion comes from
studies suggesting that thiol–disulﬁde exchange reactions may
be used to induce protein conformational changes both in some
viral fusion-active proteins and in sperm proteins active in fu-
sion. In the viral case, the most data are available for HIV,
where the proposed thiol–disulﬁde exchange is catalyzed by cell
surface protein disulﬁde isomerase (PDI) [53]. In HIV fusion,
viral gp120 binds to surface CD4 and co-receptor (CCR5 or
CXCR4), and PDI associated with CD4 on the cell surface acts
on gp120 reducing two disulﬁde bonds. This change in gp120
disulﬁdes leads to a conformational change that yields insertion
of the virus fusion peptide into the host cell plasma membrane.
Much of this model for HIV fusion is based on PDI inhibitor
studies and some alternative conclusions have been drawn with
siRNA and over-expression experiments [54]. More work will
be needed to resolve the role of PDI in HIV fusion.In other enveloped virus fusion mechanisms, disulﬁde bond
isomerization involves a viral membrane protein with PDI
activity [55]. In mammalian gamete fusion, a sperm surface
PDI family member, ERp57, has been implicated [56]. Exper-
iments with a variety of small molecule inhibitors and antibod-
ies show that reagents blocking ERp57 activity also inhibit
sperm–egg fusion [56]. In these experiments with gametes,
there is no evidence available regarding ERp57 substrate(s).6. Summary
Now that so much is known about virus–cell and intracellu-
lar fusion, cell–cell fusion may become a new frontier. In mam-
mals, egg proteins CD9, CD81 and GPI-anchored proteins and
sperm protein Izumo have been shown to be essential. Among
these, CD9 has been suggested to function as part of a CD9-
EWI-ERM-actin protein network present in egg microvilli,
but for the other proteins no speciﬁc ideas have yet been tested.
Therefore, this area seems very open to new hypotheses, results
and understanding.
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